Protein Shake and Semaglutide Study
This study is no longer recruiting additional participants.
INQUIS Clinical Research is currently recruiting participants for a research study on whether a high protein shake helps reduce side effects in people taking Ozempic/Wegovy injections.
We are looking for participants who are:
- Taking weekly injections of Ozempic or Wegovy for weight loss for at least 4 weeks
- Aged 18-75
- BMI >27 kg/m2
- No history of diabetes mellitus
- Willing to consume a high protein shake daily for 7 days
- Are able to complete questionnaires at home on an electronic device (eg. computer, laptop, smartphone)
This study involves:
- Screening visit + 2 additional in-clinic morning visits
- Consuming 1-2 high protein shakes daily for 7 days
- Filling out GI Symptoms Questionnaires (in-clinic and at home electronically)
Qualified participants are eligible to receive compensation of up to $250.
To participate, please contact studies@inquis.com